Antimicrobial Susceptibilities of Respiratory Pathogens in the Surgical/trauma Intensive Care Unit Compared with the Hospital-wide Respiratory Antibiogram in a Level I Trauma Center

Overview

Journal Surg Infect (Larchmt)

Specialties General Surgery
Infectious Diseases
Microbiology

Date 2015 Mar 12

PMID 25761081

Authors

Sara Al-Dahir

Christopher Gillard

Fatima Brakta

Julio E Figueroa

Affiliations

Soon will be listed here.

Abstract

Background: Unit-specific antibiograms have developed to guide clinicians to appropriate antibiotic choices for subsets of patients. The additional level of a unit- and respiratory-specific antibiogram for surgical and trauma patients defines key differences in susceptibility information for treating hospital-acquired pneumonia.

Methods: This was a three-year, retrospective single-center study. A total of 729 positive respiratory specimens from 612 patients were analyzed using Quality Compass Pathfinder(®), the antibiotic-reporting software. Culture and susceptibility reports were compared for the surgical/trauma intensive care unit (S/TICU) and the general hospital (excluding the S/TICU but including the medical ICU [MICU]). Data were filtered to include those genera and organisms with a high association with hospital-acquired pneumonia: Acinetobacter, Citrobacter, Enterobacter, Escherichia coli, Haemophilus, Klebsiella, Neisseria, Pseudomonas, Staphylococcus, Stenotrophomonas, Streptococcus, and Serratia.

Results: For gram-negative organisms, susceptibility differences were noted for Acinetobacter and Pseudomonas between the S/TICU and the rest of the hospital. In particular, Acinetobacter was significantly more susceptible to ciprofloxacin (86% vs. 43%; p<0.001), gentamicin (86% vs. 54%; p=0.001), imipenem-cilastatin (93% vs. 55%; p<0.001), trimethoprim-sulfamethoxazole (88% vs. 54%; p=0.001), and tobramycin (50% vs. 0; p=0.012). Pseudomonas isolates from the S/TICU were significantly more susceptible to aztreonam (83% vs. 68%; p=0.037), ciprofloxacin (86% vs. 69%; p=0.019), and imipenem-cilastatin (94% vs. 79%; p=0.01). For gram-positive organisms, Staphylococcus isolates from the S/TICU were significantly more susceptible to erythromycin (81% vs. 57%; p=0.007) and trimethoprim-sulfamethoxazole (98% vs. 91%; p=0.034) than were the hospital isolates.

Conclusions: For key respiratory pathogens, such as Pseudomonas, Acinetobacter, and Staphylococcus, surgical and trauma patients present greater susceptibility to several antibiotics. Although this information cannot be extrapolated to other institutions, it does provide a basis for comparable institutions to consider developing unit- and collection-site-specific antibiograms for infections that affect surgical/trauma patients commonly.

References

Siegel J, Rhinehart E, Jackson M, Chiarello L . Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007; 35(10 Suppl 2):S165-93. DOI: 10.1016/j.ajic.2007.10.006. View

Dellit T, Owens R, McGowan Jr J, Gerding D, Weinstein R, Burke J . Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2006; 44(2):159-77. DOI: 10.1086/510393. View

. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171(4):388-416. DOI: 10.1164/rccm.200405-644ST. View

Akulian J, Metersky M . Antibiotic resistance patterns in medical and surgical patients in a combined medical-surgical intensive care unit. J Crit Care. 2012; 28(4):347-51. DOI: 10.1016/j.jcrc.2012.02.006. View

Mueller E, Hanes S, Croce M, Wood G, Boucher B, Fabian T . Effect from multiple episodes of inadequate empiric antibiotic therapy for ventilator-associated pneumonia on morbidity and mortality among critically ill trauma patients. J Trauma. 2005; 58(1):94-101. DOI: 10.1097/01.ta.0000141890.29032.9a. View

Gillard C, Al-Dahir S, Brakta F . Observations of resistance through minimum inhibitory concentrations trends for respiratory specimens of commonly isolated organisms. Am J Health Syst Pharm. 2016; 73(5 Suppl 1):S42-8. DOI: 10.2146/sp150032. View

Bennett K, Scarborough J, Sharpe M, Dodds-Ashley E, Kaye K, Hayward 3rd T . Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit. J Trauma. 2007; 63(2):307-11. DOI: 10.1097/TA.0b013e318120595e. View

Nicasio A, Kuti J, Nicolau D . The current state of multidrug-resistant gram-negative bacilli in North America. Pharmacotherapy. 2008; 28(2):235-49. DOI: 10.1592/phco.28.2.235. View

Raymond D, Pelletier S, Crabtree T, Gleason T, Hamm L, Pruett T . Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med. 2001; 29(6):1101-8. DOI: 10.1097/00003246-200106000-00001. View

10.

Leibovici L, Paul M, Poznanski O, Drucker M, Samra Z, Konigsberger H . Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother. 1997; 41(5):1127-33. PMC: 163862. DOI: 10.1128/AAC.41.5.1127. View

11.

Acar J, Goldstein F . Consequences of increasing resistance to antimicrobial agents. Clin Infect Dis. 1998; 27 Suppl 1:S125-30. DOI: 10.1086/514913. View

12.

Becher R, Hoth J, Rebo J, Kendall J, Miller P . Locally derived versus guideline-based approach to treatment of hospital-acquired pneumonia in the trauma intensive care unit. Surg Infect (Larchmt). 2012; 13(6):352-9. DOI: 10.1089/sur.2011.056. View

13.

Kaufman D, Haas C, Edinger R, Hollick G . Antibiotic susceptibility in the surgical intensive care unit compared with the hospital-wide antibiogram. Arch Surg. 1998; 133(10):1041-5. DOI: 10.1001/archsurg.133.10.1041. View

14.

Andrews J . Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001; 48 Suppl 1:5-16. DOI: 10.1093/jac/48.suppl_1.5. View

15.

Pogue J, Alaniz C, Carver P, Pleva M, Newton D, DePestel D . Role of unit-specific combination antibiograms for improving the selection of appropriate empiric therapy for gram-negative pneumonia. Infect Control Hosp Epidemiol. 2011; 32(3):289-92. DOI: 10.1086/658665. View

16.

Mortensen J, Gerrety M, Gray L . Surveillance of antimicrobial resistance in Neisseria meningitidis from patients in the Cincinnati tristate region (Ohio, Kentucky, and Indiana). J Clin Microbiol. 2006; 44(4):1592-3. PMC: 1448648. DOI: 10.1128/JCM.44.4.1592-1593.2006. View

17.

Bonhoeffer S, Lipsitch M, Levin B . Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci U S A. 1997; 94(22):12106-11. PMC: 23718. DOI: 10.1073/pnas.94.22.12106. View

18.

Paterson D . The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis. 2006; 43 Suppl 2:S43-8. DOI: 10.1086/504476. View

19.

Harbarth S, Garbino J, Pugin J, Romand J, Lew D, Pittet D . Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003; 115(7):529-35. DOI: 10.1016/j.amjmed.2003.07.005. View

20.

Becher R, Hoth J, Neff L, Rebo J, Martin R, Miller P . Multidrug-resistant pathogens and pneumonia: comparing the trauma and surgical intensive care units. Surg Infect (Larchmt). 2011; 12(4):267-72. DOI: 10.1089/sur.2010.052. View